| 依达拉奉联合奥拉西坦治疗急性脑梗死疗效与安全性的Meta分析 |
| 投稿时间：2022-11-12 修订日期：2023-01-03 点此下载全文 |
| 引用本文：廉帅,马忠良,刘扬,张艳,张翔宇,薛孟周.依达拉奉联合奥拉西坦治疗急性脑梗死疗效与安全性的Meta分析[J].医学研究杂志,2024,53(1):50-55 |
| DOI：
10.11969/j.issn.1673-548X.2024.01.012 |
| 摘要点击次数: 78 |
| 全文下载次数: 136 |
|
| 基金项目:国家自然科学基金资助项目(82071331) |
|
| 中文摘要:目的 评估依达拉奉与奥拉西坦联合用药治疗急性脑梗死(acute cerebral infarction, ACI)的疗效与安全性。方法计算机检索PubMed、Embase、Cochrane Library、中国知网、万方数据知识服务平台等数据库,检索依达拉奉联合奥拉西坦治疗ACI的随机对照试验,检索时间为自建库至2022年10月27日,使用RevMan 5.4软件分析数据。结果 共纳入9篇研究,合计887例患者。Meta分析结果显示,观察组总有效率和Barthel指数显著高于对照组(OR=4.66,95% CI: 2.74～7.93,P＜0.001；MD=14.57,95% CI:8.58～20.56,P＜0. 001),观察组NIHSS评分显著低于对照组(MD=-5.28,95% CI: -6.42～-4.13,P＜0.001),两组不良反应发生率比较差异无统计学意义(RR=1.11,95% CI: 0.63～1.95,P=0.72)。结论 依达拉奉与奥拉西坦联合治疗ACI可以显著降低NIHSS评分,提高Barthel指数和总有效率,疗效优于依达拉奉单独用药,未来需对安全性进行更全面评价。 |
| 中文关键词:依达拉奉 奥拉西坦 急性脑梗死 Meta分析 |
| |
| Research Progress and Future Prospect of Health Recommender System |
|
|
| Abstract:Purpose/Significance To explore the research progress of health recommender system (HRS), so as to provide references for medical personnel to build HRS to help intelligent health care.Method/Process The application of common recommendation technology and HRS in the field of health care is summarized by literature research, and the research status and development direction of HRS is discussed.Result/Conclusion HRS has been applied in health service recommendation, diet recommendation, health behavior promotion, disease prognosis characteristics and health risk prediction, chronic disease management, mental health promotion and medication recommendation, and the related research is conducive to the development of intelligent health care. |
| keywords:health recommender system recommendation technique knowledge graph user portrait |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
|
|
